Magnetar Financial’s Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant IBER.U Stock Holding History

Magnetar Financial’s Portfolio IBER.U Stock Details IBER.U Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-714,500	Closed	-$7.05M	–	1844
2022 Q2	$7.05M	Sell	714,500 -63,200	-8%	-$623K	0.07%	239
2022 Q1	$7.67M	Sell	777,700 -7,209	-0.9%	-$71.8K	0.08%	241
2021 Q4	$7.87M	Sell	784,909 -18,491	-2%	-$184K	0.08%	259
2021 Q3	$8.03M	Hold	803,400	–	–	0.08%	257
2021 Q2	$8.07M	Buy	803,400 +600	+0.1%	+$6K	0.08%	256
2021 Q1	$7.92M	Buy	+802,800	New	+$8.03M	0.08%	239

Other funds holding IBER.U

Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return

SIA

Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

LCM

Landscape Capital Management Englewood, New Jersey $1.54B AUM 30.95% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

SMA

Sage Mountain Advisors Atlanta, Georgia $1.63B AUM 18.97% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Magnetar Financial's IBER.U Position: Q3 2022 in Review

Magnetar Financial sold out of Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant (IBER.U) in Q3 2022, closing a stake of 714,500 shares — an estimated $7.05M sold.

Magnetar Financial first reported a position in IBER.U in Q1 2021 and held it in 6 quarters. The position peaked at $8.07M in Q2 2021. 13 funds tracked by Wall St. Rank hold IBER.U as of Q3 2022.

Magnetar Financial reported no remaining Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant position as of Q3 2022 after selling out during the quarter.
Magnetar Financial sold 714,500 Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant shares in Q3 2022, an estimated $7.05M.
Magnetar Financial first reported a position in Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant in Q1 2021 and held it in 6 quarters.
Magnetar Financial's Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant position peaked at $8.07M in Q2 2021.
13 funds tracked by Wall St. Rank held Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant as of Q3 2022.

Based on Magnetar Financial's 13F filing for Q3 2022, filed 14 Nov 2022.